Interne link ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference september 07, 2023 om 12:00 PM UTC
Interne link ProQR Announces Second Quarter 2023 Operating and Financial Results augustus 03, 2023 om 11:00 AM UTC
Interne link ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets augustus 01, 2023 om 11:00 AM UTC
Interne link ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit juli 06, 2023 om 11:00 AM UTC
Interne link ProQR Announces First Quarter 2023 Operating and Financial Results mei 16, 2023 om 11:00 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 mei 09, 2023 om 12:00 PM UTC
Interne link ProQR Announces Upcoming Investor Conferences in April and May april 20, 2023 om 12:00 PM UTC
Interne link ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023 april 18, 2023 om 12:00 PM UTC
Interne link ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event maart 29, 2023 om 12:00 PM UTC
Interne link ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing maart 14, 2023 om 12:00 PM UTC
Interne link ProQR to Present at Upcoming Scientific and Industry Conferences maart 07, 2023 om 01:00 PM UTC
Interne link ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 februari 28, 2023 om 01:00 PM UTC
Interne link ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform december 22, 2022 om 11:15 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 november 14, 2022 om 09:30 PM UTC
Interne link ProQR Announces Third Quarter 2022 Operating and Financial Results november 09, 2022 om 12:00 PM UTC
Interne link ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference november 03, 2022 om 11:00 AM UTC
Interne link ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs augustus 11, 2022 om 11:00 AM UTC
Interne link ProQR Announces Second Quarter 2022 Operating and Financial Results augustus 04, 2022 om 11:00 AM UTC
Interne link ProQR to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium juni 28, 2022 om 11:00 AM UTC
Interne link ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates juni 01, 2022 om 11:00 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022 mei 09, 2022 om 11:00 AM UTC
Interne link ProQR Announces First Quarter 2022 Operating and Financial Results mei 05, 2022 om 08:30 PM UTC
Interne link ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision and Ophthalmology (ARVO) 2022 april 26, 2022 om 08:10 PM UTC
Interne link ProQR to Participate in the Kempen Life Sciences Conference april 19, 2022 om 08:30 PM UTC